ARGERIS N KARABELAS

CIK 1191229 · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$818.2K

Companies

6

Total Filings

59

Lifetime Open-Market Net

-$32.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RGNX Director 28,861 $6.66 $192.2K -$631.3K 18 2026-06-02
BHC Director 123,715 $5.06 $626.0K $0 4 2022-06-28
ROCKET PHARMACEUTICALS, INC. (ITEK) Delisted Director 1,609,747 $3.62M 2 2015-06-26
HUMAN GENOME SCIENCES INC (HGSI) Delisted Director 0 $0 13 2012-08-01
VNDA Director 0 $5.87 $0 -$35.52M 13 2011-06-17
NITROMED INC (NTMD) Delisted Director $0 2 2008-05-16

Recent Filings · Page 2 of 6

59 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-06-07 RGNX Grant (A) +3,010 $0 EDGAR
2021-06-08 RGNX Grant (A) $0 EDGAR
2021-05-03 BHC Grant (A) +7,645 $0 EDGAR
2020-06-02 RGNX Grant (A) $0 EDGAR
2020-05-01 BHC Grant (A) +11,037 $0 EDGAR
2019-06-04 RGNX Grant (A) $0 EDGAR
2019-05-03 BHC Grant (A) +10,633 $250.0K EDGAR
2018-05-30 RGNX Grant (A) $0 EDGAR
2018-05-08 Grant (A) +13,881 $0
2018-05-04 Grant (A) +14,285 $0
Showing 1120 of 59
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.